Get started
Author

Danielle Burke

ORCID: 0000-0002-6146-869X
Observed ORCID: 0000-0002-6146-869X
OpenAlex ID: A5036088006
Humanized Patient-derived Xenograft Models of Disseminated Ovarian Cancer Recapitulate Key Aspects of the Tumor Immune Environment within the Peritoneal Cavity
2023 · Mara P. Steinkamp, Irina Lagutina, et al. · Cancer Research Communications · 27
The Influence of Macrophages within the Tumor Microenvironment on Ovarian Cancer Growth and Response to Therapies
2025 · Parisa Nikeghbal, Danielle Burke, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 4
PDF
Humanized NBSGW PDX Models of Disseminated Ovarian Cancer Recapitulate Key Aspects of the Tumor Immune Environment within the Peritoneal Cavity
2022 · Mara P. Steinkamp, Irina Lagutina, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Clinical translation of TLR agonist-modified silicified cancer cell therapy supported by humanized mouse models
2025 · Mara P. Steinkamp, Danielle Burke, et al. · Molecular Therapy Oncology
Abstract B066: TLR-agonist modified mesoporous silica nanoparticles stimulate T cell-mediated anti-cancer immune responses following intraperitoneal delivery in HLA-A 2.1 allele PDX ovarian cancer models in humanized NBSGW mice
2025 · Rita E. Serda, Ellie Kennedy, et al. · Cancer Research
POSTER: CT-102 The Influence of Macrophages Within the Tumor Microenvironment on Ovarian Cancer Growth and Response to Therapies
2025 · Parisa Nikeghbal PhD Candidate, Danielle Burke, et al. · Clinical Lymphoma Myeloma & Leukemia
FIGURE 3 from Humanized Patient-derived Xenograft Models of Disseminated Ovarian Cancer Recapitulate Key Aspects of the Tumor Immune Environment within the Peritoneal Cavity
2024 · Mara P. Steinkamp, Irina Lagutina, et al.
FIGURE 1 from Humanized Patient-derived Xenograft Models of Disseminated Ovarian Cancer Recapitulate Key Aspects of the Tumor Immune Environment within the Peritoneal Cavity
2024 · Mara P. Steinkamp, Irina Lagutina, et al.
FIGURE 7 from Humanized Patient-derived Xenograft Models of Disseminated Ovarian Cancer Recapitulate Key Aspects of the Tumor Immune Environment within the Peritoneal Cavity
2024 · Mara P. Steinkamp, Irina Lagutina, et al.
FIGURE 4 from Humanized Patient-derived Xenograft Models of Disseminated Ovarian Cancer Recapitulate Key Aspects of the Tumor Immune Environment within the Peritoneal Cavity
2024 · Mara P. Steinkamp, Irina Lagutina, et al.
FIGURE 4 from Humanized Patient-derived Xenograft Models of Disseminated Ovarian Cancer Recapitulate Key Aspects of the Tumor Immune Environment within the Peritoneal Cavity
2024 · Mara P. Steinkamp, Irina Lagutina, et al.
FIGURE 2 from Humanized Patient-derived Xenograft Models of Disseminated Ovarian Cancer Recapitulate Key Aspects of the Tumor Immune Environment within the Peritoneal Cavity
2024 · Mara P. Steinkamp, Irina Lagutina, et al.
FIGURE 2 from Humanized Patient-derived Xenograft Models of Disseminated Ovarian Cancer Recapitulate Key Aspects of the Tumor Immune Environment within the Peritoneal Cavity
2024 · Mara P. Steinkamp, Irina Lagutina, et al.
FIGURE 1 from Humanized Patient-derived Xenograft Models of Disseminated Ovarian Cancer Recapitulate Key Aspects of the Tumor Immune Environment within the Peritoneal Cavity
2024 · Mara P. Steinkamp, Irina Lagutina, et al.
FIGURE 6 from Humanized Patient-derived Xenograft Models of Disseminated Ovarian Cancer Recapitulate Key Aspects of the Tumor Immune Environment within the Peritoneal Cavity
2024 · Mara P. Steinkamp, Irina Lagutina, et al.
FIGURE 7 from Humanized Patient-derived Xenograft Models of Disseminated Ovarian Cancer Recapitulate Key Aspects of the Tumor Immune Environment within the Peritoneal Cavity
2024 · Mara P. Steinkamp, Irina Lagutina, et al.
TABLE 1 from Humanized Patient-derived Xenograft Models of Disseminated Ovarian Cancer Recapitulate Key Aspects of the Tumor Immune Environment within the Peritoneal Cavity
2024 · Mara P. Steinkamp, Irina Lagutina, et al.
FIGURE 6 from Humanized Patient-derived Xenograft Models of Disseminated Ovarian Cancer Recapitulate Key Aspects of the Tumor Immune Environment within the Peritoneal Cavity
2024 · Mara P. Steinkamp, Irina Lagutina, et al.
FIGURE 5 from Humanized Patient-derived Xenograft Models of Disseminated Ovarian Cancer Recapitulate Key Aspects of the Tumor Immune Environment within the Peritoneal Cavity
2024 · Mara P. Steinkamp, Irina Lagutina, et al.
FIGURE 3 from Humanized Patient-derived Xenograft Models of Disseminated Ovarian Cancer Recapitulate Key Aspects of the Tumor Immune Environment within the Peritoneal Cavity
2024 · Mara P. Steinkamp, Irina Lagutina, et al.
FIGURE 5 from Humanized Patient-derived Xenograft Models of Disseminated Ovarian Cancer Recapitulate Key Aspects of the Tumor Immune Environment within the Peritoneal Cavity
2024 · Mara P. Steinkamp, Irina Lagutina, et al.
TABLE 1 from Humanized Patient-derived Xenograft Models of Disseminated Ovarian Cancer Recapitulate Key Aspects of the Tumor Immune Environment within the Peritoneal Cavity
2024 · Mara P. Steinkamp, Irina Lagutina, et al.
Abstract A085: Evaluating the immune modulating effects of standard chemotherapies and macrophage-targeted therapy in a humanized patient-derived xenograft model of high grade ovarian cancer
2024 · Mara P. Steinkamp, Danielle Burke, et al. · Cancer Research
Table S2 from Humanized Patient-derived Xenograft Models of Disseminated Ovarian Cancer Recapitulate Key Aspects of the Tumor Immune Environment within the Peritoneal Cavity
2023 · Mara P. Steinkamp, Irina Lagutina, et al.
Figure S3 from Humanized Patient-derived Xenograft Models of Disseminated Ovarian Cancer Recapitulate Key Aspects of the Tumor Immune Environment within the Peritoneal Cavity
2023 · Mara P. Steinkamp, Irina Lagutina, et al.
PDF
Works count: 43
Citation count: 32
H-index: 2
I10-index: 1
Year
Topic
Type